Loading stock data…
PHAR
$16.98+0.45 (+2.72%)
Market ClosedLast close May 1
Pharming Group N.V., a biopharmaceutical company, develops and commercializes protein replacement therapies and precision medicines for the treatment of rare diseases in the United States, Europe, and internationally.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Pharming Group N.V. in the Healthcare sector is trading at $16.98. The stock is currently 20% below its 52-week high of $21.34, remaining 9.7% above its 200-day moving average. Technical signals show neutral RSI of 50 and bearish MACD signal, explaining why PHAR maintains its current momentum and trend strength. The Whystock Score of 95/100 reflects a high-conviction bullish alignment.
Ecosystem Influences
Neutral momentum (RSI 50) — price action in range
Long-term trend bullish (Price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Loading Financials...
Peer Comparison
JNJUNHPFE
Whystock Valuation Model
Whystock fair value is estimated using a trailing P/E model adjusted for return on equity: Fair P/E = 18 + (ROE × 20). Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. A base P/E of 18 represents a typical market multiple, scaled upward for companies that earn high returns on equity. The result is a theoretical "normalised" price — not a price target or investment advice. Large deviations are common for high-growth or loss-making companies.
Current Price$16.98
Potential Downside
95.2%
Whystock Fair Value$0.81
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Analyst Consensus4 analysts
Mean target$34.60+103.8%
Range$23.40 – $41.00
Fundamentals
Pharming Group N.V., a biopharmaceutical company, develops and commercializes protein replacement therapies and precision medicines for the treatment of rare diseases in the United States, Europe, and internationally. The company's lead product is RU...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$1.19B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
423.00
Beta
Defensive asset. Lower volatility than the S&P 500.
0.12
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
10.96%
Volume
Today's trading volume
2,111
Recent News
3 European Penny Stocks With Market Caps Over €10M
European markets have recently seen a boost in investor sentiment, with the pan-European STOXX Europe 600 Index climbing over 3% following a temporary ceasefire between the U.S. and Iran. Amid these developments, investors are increasingly exploring diverse opportunities to navigate potential economic challenges, including rising inflation and growth forecast adjustments by the EU. Penny stocks, despite their somewhat outdated moniker, continue to attract attention for their potential value;...
Discovering European Penny Stocks: Lemonsoft Oyj And 2 More Promising Picks
European markets have recently experienced a rally, with the pan-European STOXX Europe 600 Index climbing over 3% amid easing geopolitical tensions following a U.S.-Iran ceasefire agreement. For investors interested in exploring beyond the established giants, penny stocks—typically smaller or newer companies—can present intriguing opportunities. Although the term may seem outdated, these stocks can still offer substantial value when they possess strong financial foundations and potential for...
European Penny Stocks To Watch In April 2026
As European markets rally following the U.S.-Iran ceasefire, investor sentiment has improved, with major indexes like Germany's DAX and France's CAC 40 posting significant gains. Amidst this backdrop of cautious optimism, penny stocks—often smaller or newer companies—continue to present intriguing opportunities for investors seeking growth potential. While the term "penny stocks" might seem outdated, their relevance persists as they offer a unique blend of affordability and financial strength...
3 European Penny Stocks With Market Caps Over €30M
The European market has recently seen a boost in sentiment, with the pan-European STOXX Europe 600 Index rising by 3.92%, as hopes for a shorter-lived Middle East conflict have improved investor outlooks. Amid these broader market dynamics, penny stocks—typically smaller or newer companies—remain an intriguing area for investors seeking growth opportunities at lower price points. Although the term "penny stocks" might seem outdated, these investments can still offer substantial potential when...
3 European Penny Stocks With Market Caps Under €40M
The European markets have seen a positive shift, with the STOXX Europe 600 Index rising by 3.92% amid hopes of a shorter-than-expected Middle East conflict. As investors navigate this evolving landscape, penny stocks—despite their somewhat outdated moniker—remain an intriguing segment for those seeking potential growth opportunities at lower price points. These smaller or newer companies often offer unique value propositions, and when supported by strong financials, they can present...